Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
Product Unit Size | Cost | Quantity | Stock |
---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
Purity | ≥98% |
---|---|
Formula | C33H59N11O10 |
Formula Wt. | 769.90 |
Solubility | Soluble in water (2 mg/mL), acetonitrile. |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
DPP4 inhibitor.
5-HT7 and D2/3 antagonist.
Found in Cephalosporium; fatty acid synthase in...
Lck, Src, SIK inhibitor.
Light-emitting luciferin analog found in aquati...
Juvenille insect growth hormone analog.
ITC found in cruciferous vegetables; HDAC inhib...
Isoquinoline alkaloid found in Corydalis, Phell...
Endogenous anionic non-sulfated glycosaminoglyc...
Macrolide lactone found in Bugula; TLR4 activat...
Opioid peptide; δOR agonist.
Phosphodiesterase inhibitor that produces anti-...
Statin; HMG-CoA reductase inhibitor, potential ...
Phenolic phytoalexin found in soy, grapes, and ...
Endogenous peptide involved in vascular contrac...
Oligodendrocyte antigen used to induce EAE.
K+ channel blocker, catecholamine release stimu...
PLK1 inhibitor.
Somewhat selective in inhibiting COX-2 over COX...
Peptide, GLP-1 analog found in Heloderma; GLP-1...